- Hero MotoCorp’s vehicle sales in July 2024 were 370,274 units.
- This represents a 5.4% decrease compared to the same period last year (391,310 units).
- Motorcycle sales specifically were 340,390 units, down 5.6% year-on-year.
- On a positive note, exports increased by 13% year-on-year, reaching 22,739 units.
- Market sentiment: 28 analysts recommend buying, 7 suggest holding, and 8 advise selling the stock.
A look at Hero Motocorp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Hero MotoCorp Ltd., a company known for designing, manufacturing, and distributing motorcycles along with motorcycle parts and accessories, seems to have a promising long-term outlook based on the Smartkarma Smart Scores. With a strong emphasis on providing dividends to its investors, Hero Motocorp scores a perfect 5 in the Dividend category, indicating a reliable payout to shareholders. Additionally, the company is rated highly in terms of resilience, scoring a 5, which suggests its ability to withstand economic challenges and market fluctuations. This resilience coupled with a decent growth score of 3 reflects a stable growth trajectory for the company in the foreseeable future.
Although Hero Motocorp scores moderately in the Value and Momentum categories with a score of 3 each, the overall outlook remains positive based on its strong performance in Dividend and Resilience. Investors looking for a company with consistent dividend payments and a sturdy market position may find Hero Motocorp an attractive long-term investment option, supported by its robust fundamentals and strategic focus on shareholder returns.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
